Apollon Wealth Management’s Zymeworks ZYME Stock Holding History

Apollon Wealth Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,875	Closed	-$207K	–	1469
2025 Q4	$207K	Buy	+7,875	New	+$172K	﹤0.01%	1214

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Apollon Wealth Management's ZYME Position: Q1 2026 in Review

Apollon Wealth Management sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 7,875 shares — an estimated $207K sold.

Apollon Wealth Management first reported a position in ZYME in Q4 2025 and held it in 1 quarter. The position peaked at $207K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

Apollon Wealth Management reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
Apollon Wealth Management sold 7,875 Zymeworks shares in Q1 2026, an estimated $207K.
Apollon Wealth Management first reported a position in Zymeworks in Q4 2025 and held it in 1 quarter.
Apollon Wealth Management's Zymeworks position peaked at $207K in Q4 2025.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.